These findings establish the 7-DHC–DHCR7 axis as a critical checkpoint in ferroptosis regulation and highlight its therapeutic potential as a target for enhancing ferroptosis in cancer therapy or suppressing ferroptosis in acute tissue injury (29, 30). Here, DHCR7 is linked to cancer.